staurosporine has been researched along with acetovanillone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fleer, A; Mattsson, E; Rollof, J; Van Dijk, H; Van Kessel, K; Verhoef, J | 1 |
| Csiszar, A; Kaminski, PM; Koller, A; Ungvari, Z; Wolin, MS | 1 |
| Cangemi, R; Carnevale, R; Celestini, A; Ferro, D; Loffredo, L; Martini, A; Pignatelli, P; Polimeni, L; Violi, F | 1 |
3 other study(ies) available for staurosporine and acetovanillone
| Article | Year |
|---|---|
Intracellular pathways involved in tumor necrosis factor-alpha release by human monocytes on stimulation with lipopolysaccharide or staphylococcal peptidoglycan are partly similar.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Acetophenones; Alkaloids; Antimalarials; Cell Communication; Chloroquine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Escherichia coli; GTP-Binding Proteins; Humans; Isoquinolines; Lipopolysaccharides; Monocytes; Pentoxifylline; Peptidoglycan; Piperazines; Protein Kinase Inhibitors; Protein Kinases; Protein-Tyrosine Kinases; Signal Transduction; Staphylococcus epidermidis; Staurosporine; Sulfonamides; Tumor Necrosis Factor-alpha; Vasodilator Agents | 1996 |
Chronic high pressure-induced arterial oxidative stress: involvement of protein kinase C-dependent NAD(P)H oxidase and local renin-angiotensin system.
Topics: Acetophenones; Acetylcholine; Alkaloids; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteries; Benzophenanthridines; Captopril; Enzyme Inhibitors; Hypertension; Male; Models, Biological; NADPH Oxidases; Nitric Oxide Donors; Nitric Oxide Synthase; Onium Compounds; Organ Culture Techniques; Oxidative Stress; Penicillamine; Phenanthridines; Protein Kinase C; Rats; Rats, Wistar; Renin-Angiotensin System; Staurosporine; Superoxide Dismutase; Vasoconstrictor Agents; Vasodilator Agents | 2004 |
Tumour necrosis factor alpha upregulates platelet CD40L in patients with heart failure.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Acetophenones; Aged; Aged, 80 and over; Arachidonic Acids; Aspirin; Blood Platelets; Case-Control Studies; CD40 Ligand; Cyclooxygenase 1; Deoxyguanosine; Enzyme Inhibitors; Female; Heart Failure; Humans; Male; Middle Aged; NADPH Oxidases; Oxidative Stress; Phospholipase A2 Inhibitors; Phospholipases A2; Protein Kinase C; Receptors, Tumor Necrosis Factor; Severity of Illness Index; Signal Transduction; Staurosporine; Tumor Necrosis Factor-alpha; Up-Regulation | 2008 |